Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
about
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular systemPossible site of action of CGRP antagonists in migraine.A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasationCalcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization.Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review.Differential inhibitory response to telcagepant on αCGRP induced vasorelaxation and intracellular Ca2+ levels in the perfused and non-perfused isolated rat middle cerebral artery.Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients.Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists.CGRP blockers in migraine therapy: where do they act?The blood-brain barrier in migraine treatment.Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraineCGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?CGRP receptor antagonism and migraine.Calcitonin gene-related peptide: an update on the biology.The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine.The PACAP receptor: a novel target for migraine treatment.Late cerebral ischaemia after subarachnoid haemorrhage: is cerebrovascular receptor upregulation the mechanism behind?Chemical mediators of migraine: preclinical and clinical observations.CGRP receptor antagonists: design and screening.Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.Targeting CGRP: A New Era for Migraine Treatment.The Journey to Establish CGRP as a Migraine Target: A Retrospective View.CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus.CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat.Evidence for CGRP re-uptake in rat dura mater encephali.Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes.Characterization of a mouse model of headacheBlocking CGRP in migraine patients - a review of pros and cons.Triptans and CGRP blockade - impact on the cranial vasculature.CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine.Perivascular neurotransmitters: Regulation of cerebral blood flow and role in primary headaches.Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.Effect of a calcitonin gene-related peptide-binding L-RNA aptamer on neuronal activity in the rat spinal trigeminal nucleus.Elevated levels of calcitonin gene-related peptide in upper spinal cord promotes sensitization of primary trigeminal nociceptive neurons.
P2860
Q24646305-497CA646-6F87-4CFF-A8AB-2A7C8D6DC557Q34169056-374F13DE-E6D7-49F7-91E9-C2AB8488F5DFQ35693015-55DAD826-1CF5-4B91-A101-AE203CA62890Q35704108-D5FF6E42-0E20-4907-807D-BC153121A573Q36260321-FB9257A5-C33B-46C6-804E-85E24193B9AAQ36385789-F33CF903-BBE3-43C5-A4FA-CE0A6CE1C7D6Q36662434-E1549D6F-0A3B-40FF-A743-EB41B7D3BC9BQ36936344-D76E48E8-C52E-4EE8-AEF2-F2113D35E3D5Q37002379-8404AA51-84ED-4998-BE56-AF23DF16DFB3Q37252452-36A70D8E-98CB-46F5-8D36-9071EB818E49Q37276146-E9BD028E-2156-45E7-9729-AF051B34A71BQ37337815-0E868FBD-F386-4672-BB40-837FB061EA21Q37374122-64F84E1C-6050-43A8-965D-6EB1CCE97362Q37478413-6E7AEB50-7FBC-4422-83D8-A457CC35A189Q37713262-D9112F6D-7127-4ED3-B395-CF6AB2BACEE8Q37739591-5ECEE0A8-3B35-407E-AF1E-8D31802E1A90Q37810632-0317F357-15A0-4A13-8900-6BC932403A25Q37883455-78BFE381-B792-438D-8FD6-1B52ECCA3CE2Q38088346-12CAA93E-8AD9-4D8B-B61F-BD7A350D29B7Q38130336-A63E303E-FAFF-4B86-9647-7B8DAC33586BQ38542176-352E1A17-06FD-4FC1-A740-DB13815645DDQ38561443-A45EF92F-8CA6-4CB6-9F63-5D3382587210Q39193269-6A9AA5A2-63CE-48C8-8ABB-9CF24DB0EB18Q39298115-1740F19A-A5D2-4BD9-865D-3D4203BB8182Q39948717-C1861533-EE29-466F-B963-A560A4522863Q41139207-4BD4C59D-5EDD-4444-A508-C26DA5BA33C7Q41485636-44FB1A06-5AB3-4968-BD93-F985D876A834Q42012334-634A3781-0EE6-45F3-BAD7-03B6271AA871Q42175618-C39FE7F3-62D3-45B3-B214-251AFC0F06B4Q42363673-5F1AE6CA-1B4D-46D4-B189-6F30859E4180Q42706186-9F371693-57D1-4621-B58F-60D19BC665B2Q42854065-29235A24-E6F4-4A44-98D6-8EC7A6D522F0Q47676203-2A7D82E6-A176-46D6-A48F-834241A2E45BQ47819343-8DE492E0-6C5B-4B92-A53B-EDEED25D92E9Q50041816-9C157E3F-3C4C-408F-8C96-525B5FFAFA5BQ50195366-8FCC0D37-4879-459E-BC45-221238A28FE0
P2860
Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inhibitory effect of BIBN4096B ...... ed rat middle cerebral artery.
@en
type
label
Inhibitory effect of BIBN4096B ...... ed rat middle cerebral artery.
@en
prefLabel
Inhibitory effect of BIBN4096B ...... ed rat middle cerebral artery.
@en
P2860
P356
P1476
Inhibitory effect of BIBN4096B ...... sed rat middle cerebral artery
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0707134
P407
P577
2007-01-22T00:00:00Z